NCT02933658View on ClinicalTrials.gov

Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2015

Conditions
Hypertension and Dyslipidemia
Interventions
DRUG

Telmisartan

DRUG

Amlodipine

DRUG

Rosuvastatin

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT02933658 - Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter